ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 8,500.00
-510.00 (-5.66%)
At close: Mar 19, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 645.98 billion as of March 20, 2026.
Market Cap
645.98B
Enterprise Value
622.61B
Revenue
111.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
8,500.00
Market Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has increased from 547.53B to 645.98B, an increase of 17.98%. That is a compound annual growth rate of 21.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 645.98B | -33.10% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 1.46T |
| Myung In Pharmaceutical LTD. | 858.48B |
| Samyang Biopharm | 756.23B |
| HEM Pharma | 502.02B |
| CellBion | 396.49B |
| DAE HWA Pharmaceutical | 257.32B |
| NOVAREX | 238.80B |
| OPTUS Pharmaceutical | 210.17B |